About NIA

Alzheimer’s Prevention Trial Using a Statin Drug

Thursday, September 12, 2002

Statins may be useful in preventing Alzheimer’s disease, based on results from several recent epidemiological studies and basic science considerations. However, there are biological, clinical, and methodological issues that need to be addressed before the Division of Neuroscience, NIA can consider support of such a prevention trial. Scientists with basic science, clinical, epidemiological, and intervention trial expertise on statins were invited to this advisory meeting to delineate and clarify important issues in the conception of such a trial.

Contact Information
Dr.Neil Buckholtz